Watson Pharmaceuticals (WPI) confirms it will buy Actavis Group for at least €4.25B euros...
Watson Pharmaceuticals (WPI) confirms it will buy Actavis Group for at least €4.25B euros ($5.60B), in a deal that cements its status as one of the world's biggest suppliers of generic drugs. WPI +5.5% AH.
From other sites
Video at CNBC.com (Mon, 11:40AM)
at CNBC.com (Feb 18, 2015)
at CNBC.com (Feb 10, 2015)
at CNBC.com (Feb 5, 2015)
at CNBC.com (Jan 30, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs